Pharmacyclics, Inc. (NASDAQ:PCYC.DL)

CAPS Rating: No stars

A pharmaceutical company focused on the development of products that improve existing therapeutic approaches to cancer and other diseases.

PCYC.DL News and Commentary

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top PCYC.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

philiplbrooks (< 20)
Submitted January 09, 2014

Imbruvica appears to be an amazing drug and has enormous potential in chronic lymphocytic lymphoma, low grade lymphomas and high grade lymphomas. Once in use, I think it will be used in multiple lines of treatment for these diseases and in… More

kdakota630 (29.17)
Submitted February 25, 2015

I really regret giving this one the red thumb.

PCYC.DL VS S&P 500 (SPY)

PCYC.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about PCYC.DL.

No one has written a Pitch for PCYC.DL stock yet. Tell us why you think PCYC.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in PCYC.DL.

No players have picked PCYC.DL yet. Tell us why you think PCYC.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
tracknomura 94.85 2/19/2015 Outperform NS $168.05 +55.46% +1.71% +53.75 5/25/2015 @ $261.25 0 Comment
TrackRothCapital 76.83 10/17/2014 Outperform NS $114.11 +128.95% +13.04% +115.91 5/25/2015 @ $261.25 0 Comment
TrackGoldmanSach 73.87 10/11/2013 Outperform NS $131.50 +98.67% +26.10% +72.57 5/25/2015 @ $261.25 0 Comment
TrackJimCramer 85.59 9/27/2013 Outperform 3W $132.49 +97.18% +26.10% +71.09 5/25/2015 @ $261.25 0 Comment
TrackRBCCapMkts 87.36 5/13/2013 Outperform NS $82.50 +3.14% +17.08% -13.94 5/27/2014 @ $85.09 0 Comment
TrackCreditSuiss 89.00 1/15/2013 Outperform NS $65.87 +296.61% +45.59% +251.02 5/25/2015 @ $261.25 0 Comment
TrackLazardCapit 79.66 8/7/2012 Outperform NS $57.10 +357.53% +51.94% +305.59 5/25/2015 @ $261.25 0 Comment
TrackRBCCapMkts 87.36 2/21/2012 Outperform NS $25.37 +161.63% +3.30% +158.33 8/28/2012 @ $66.38 0 Comment
TrackRodmanRen < 20 12/7/2011 Outperform NS $15.44 +1,592.03% +69.25% +1,522.78 5/25/2015 @ $261.25 0 Comment
TrackNeedham 90.83 11/11/2011 Outperform NS $11.29 +2,213.99% +69.27% +2,144.73 5/25/2015 @ $261.25 0 Comment
TrackUltraLong < 20 11/4/2011 Underperform NS $13.02 +1,906.53% +70.08% -1,836.45 5/25/2015 @ $261.25 1 Comment
TrackRBCCapMkts 87.36 6/20/2011 Outperform NS $9.35 +32.62% -0.68% +33.30 12/9/2011 @ $12.40 0 Comment
trackglobalhunte < 20 5/27/2011 Outperform NS $7.13 +87.24% -6.02% +93.26 12/9/2011 @ $13.35 0 Comment
TrackWedbush 87.56 6/7/2010 Outperform NS $5.80 +4,404.31% +100.16% +4,304.15 5/25/2015 @ $261.25 0 Comment
TrackRothCapital 76.83 3/12/2010 Outperform NS $5.54 +14.80% +16.77% -1.97 5/3/2011 @ $6.36 0 Comment
trackmerriman 68.80 1/29/2010 Outperform NS $4.16 +6,180.05% +95.33% +6,084.72 5/25/2015 @ $261.25 0 Comment
TrackBWS 96.62 4/9/2007 Underperform NS $3.15 -32.47% -0.41% +32.06 8/17/2007 @ $2.13 0 Comment
TrackTWeisel 87.49 11/20/2006 Outperform NS $6.12 -47.88% +4.05% -51.93 2/21/2007 @ $3.19 0 Comment

Featured Broker Partners


Advertisement